Top compounds associated with response to SPRY2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 3e-15
mRNA AZ628 GDSC1000 pan-cancer AAC 0.3 1e-08
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.3 8e-17
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.31 9e-10
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.31 1e-18
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.32 2e-17
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.33 3e-23
mRNA PD318088 CTRPv2 pan-cancer AAC 0.33 4e-19
mRNA AZD6244 FIMM pan-cancer AAC 0.35 0.04
mRNA Erlotinib UHNBreast pan-cancer AAC 0.35 0.2
Download CSV